Related Experiment Video
Updated: Jun 26, 2026
09:45
Simultaneous Measurements of Intracellular Calcium and Membrane Potential in Freshly Isolated and Intact Mouse Cerebral Endothelium
Published on: January 20, 2019
Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?
1Department of Angiology, Institut de Recherches Servier, Suresnes, France. michel.feletou@fr.netgrs.com
British Journal of Pharmacology
|February 4, 2009
Summary
Calcium-activated potassium channels (K(Ca)) in blood vessels regulate vascular tone. Activating these channels may treat endothelial dysfunction, while blocking specific subtypes could prevent restenosis or sepsis-induced hypotension.
Area of Science:
- Cardiovascular Physiology
- Molecular Biology
- Pharmacology
Background:
- Calcium-activated potassium channels (K(Ca)) of large (BK(Ca)), intermediate (IK(Ca)), and small (SK(Ca)) conductance are crucial in vascular health.
- BK(Ca) channels are mainly in smooth muscle cells, while IK(Ca) and SK(Ca) are in endothelial cells, regulating vascular tone and responses.
Purpose of the Study:
- To explore the role of K(Ca) channel subtypes in endothelial function and dysfunction.
- To investigate the therapeutic potential of targeting K(Ca) channels for cardiovascular diseases.
Main Methods:
- Review of existing literature on K(Ca) channel expression and function in the vascular wall.
- Analysis of signaling pathways involving K(Ca) channels, endothelium-derived factors, and vascular responses.
Main Results:
- Endothelial IK(Ca) and SK(Ca) activation promotes nitric oxide (NO) generation and endothelium-dependent hyperpolarizations.
- Endothelium-derived factors activate BK(Ca) channels, leading to smooth muscle relaxation, while others inhibit them.
- Aging and cardiovascular diseases impair endothelial function, affecting K(Ca) channel activity and NO bioavailability.
Conclusions:
- Modulating K(Ca) channel activity presents a potential therapeutic strategy for endothelial dysfunction.
- Targeting specific K(Ca) channel subtypes may offer treatments for restenosis (IK(Ca) blockers) or sepsis-induced hypotension (BK(Ca) blockers).
More Related Videos
Related Concept Videos
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...